[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE69832267D1 - Oberflächige verwendung von probiotischen bacillussporen zur verhinderung oder bekämpfung von mikrobiellen infektionen - Google Patents

Oberflächige verwendung von probiotischen bacillussporen zur verhinderung oder bekämpfung von mikrobiellen infektionen

Info

Publication number
DE69832267D1
DE69832267D1 DE69832267T DE69832267T DE69832267D1 DE 69832267 D1 DE69832267 D1 DE 69832267D1 DE 69832267 T DE69832267 T DE 69832267T DE 69832267 T DE69832267 T DE 69832267T DE 69832267 D1 DE69832267 D1 DE 69832267D1
Authority
DE
Germany
Prior art keywords
prevent
microbial infections
surface use
bacillus spores
probiotic bacillus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69832267T
Other languages
English (en)
Other versions
DE69832267T2 (de
Inventor
Sean Farmer
J Mikhail
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ganeden Biotech Inc
Original Assignee
Ganeden Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ganeden Biotech Inc filed Critical Ganeden Biotech Inc
Publication of DE69832267D1 publication Critical patent/DE69832267D1/de
Application granted granted Critical
Publication of DE69832267T2 publication Critical patent/DE69832267T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/20—Bacteria; Substances produced thereby or obtained therefrom
    • A01N63/22—Bacillus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Environmental Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69832267T 1997-04-18 1998-04-10 Oberflächige verwendung von probiotischen bacillussporen zur verhinderung oder bekämpfung von mikrobiellen infektionen Expired - Lifetime DE69832267T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4464397P 1997-04-18 1997-04-18
US44643P 1997-04-18
PCT/US1998/007307 WO1998047374A1 (en) 1997-04-18 1998-04-10 Topical use of probiotic bacillus spores to prevent or control microbial infections

Publications (2)

Publication Number Publication Date
DE69832267D1 true DE69832267D1 (de) 2005-12-15
DE69832267T2 DE69832267T2 (de) 2006-08-10

Family

ID=21933508

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69832267T Expired - Lifetime DE69832267T2 (de) 1997-04-18 1998-04-10 Oberflächige verwendung von probiotischen bacillussporen zur verhinderung oder bekämpfung von mikrobiellen infektionen
DE69842080T Expired - Lifetime DE69842080D1 (de) 1997-04-18 1998-04-10 Oberflächige Verwendung von probiotischen Bacillussporen zur Verhinderung oder Bekämpfung von mikrobiellen Infektionen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69842080T Expired - Lifetime DE69842080D1 (de) 1997-04-18 1998-04-10 Oberflächige Verwendung von probiotischen Bacillussporen zur Verhinderung oder Bekämpfung von mikrobiellen Infektionen

Country Status (9)

Country Link
US (2) US20090186057A1 (de)
EP (2) EP1629846B1 (de)
JP (2) JP4678896B2 (de)
AT (2) ATE493139T1 (de)
AU (1) AU749001B2 (de)
CA (1) CA2287451C (de)
DE (2) DE69832267T2 (de)
ES (1) ES2255730T3 (de)
WO (1) WO1998047374A1 (de)

Families Citing this family (113)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2020959C1 (ru) * 1991-10-21 1994-10-15 Игорь Дмитриевич Поляков Вакцина поливак-тм для профилактики и лечения дерматофитозов животных
WO2001034168A1 (en) * 1999-11-08 2001-05-17 Ganeden Biotech, Inc. Inhibition of pathogens by bacillus coagulans strains
US6645506B1 (en) 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
US6716435B1 (en) 1997-04-18 2004-04-06 Ganeden Biotech, Inc. Absorbent product containing absorbent structure and Bacillus coagulans
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US7767203B2 (en) 1998-08-07 2010-08-03 Ganeden Biotech, Inc. Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
EP1173233A1 (de) * 1999-04-14 2002-01-23 Ganeden Biotech, Inc. Verfahren zur inhibierung mikrobieller infektionen verbunden mit sanitärprodukten
US6264967B1 (en) * 1999-07-14 2001-07-24 Shinei Fermentec Corporation Method for eliminating Staphylococcus aureus, novel microorganism of genus Brachybacterium, and care garment, care sheet or care bedclothes, each being immobilized with microorganism of genus Brachybacterium
AU783905B2 (en) * 1999-08-26 2005-12-22 Ganeden Biotech, Inc. Use of emu oil carrier for antifungal, antibacterial, and antiviral medications
WO2001013956A2 (en) * 1999-08-26 2001-03-01 Ganeden Biotech, Inc. Use of emu oil a carrier for antifungal, antibacterial, and antiviral medications
US6849256B1 (en) 1999-11-08 2005-02-01 Ganeden Biotech Incorporated Inhibition of pathogens by probiotic bacteria
EP1110555A1 (de) 1999-12-22 2001-06-27 Societe Des Produits Nestle S.A. Anti-adhäsives Agens für die pathogene Hautflora
US6967025B2 (en) * 2000-01-18 2005-11-22 The Procter & Gamble Company Articles with spores exhibiting antagonistic properties against pathogens and/or spores forming micro-organisms
EP1263483B1 (de) * 2000-01-18 2007-03-07 The Procter & Gamble Company Artikel mit sporen die antagonistische eigenschaften gegen pathogene aufweisen und/oder sporen die mikroorganismen bilden
EP1118343A1 (de) * 2000-01-18 2001-07-25 The Procter & Gamble Company Artikel mit Sporen die antagonistische Eigenschaften gegen Pathogene aufweisen
EP1118342A1 (de) * 2000-01-18 2001-07-25 The Procter & Gamble Company Artikel mit einem sporenbildenden milchsäureproduzierenden Mikroorganismus
SE518097C2 (sv) * 2000-10-03 2002-08-27 Ellen Ab Förfarande för framställning av en absorberande sanitetsartikel som innefattar mjölksyraproducerande bakterier samt sådant alster
JP2002113041A (ja) 2000-10-11 2002-04-16 Uni Charm Corp 皮膚常在菌をコントロールする吸収性物品
WO2003030953A1 (en) * 2001-10-02 2003-04-17 Kimberly-Clark Worldwide, Inc. Inhibition of exoprotein production using aromatic compositions
SE0104199L (sv) * 2001-12-13 2003-06-14 Sca Hygiene Prod Ab Ny produkt
US20030143262A1 (en) 2001-12-13 2003-07-31 Brusk Ulla Forsgren Hygiene tissue
ITMI20030643A1 (it) 2003-04-01 2004-10-02 Copan Innovation Ltd Tampone per il prelievo di campioni biologici
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
JP2005299025A (ja) * 2004-04-13 2005-10-27 Nami Kazuji 抗ウイルス性バイオシート繊維体
US8110215B2 (en) * 2004-04-30 2012-02-07 Kimberly-Clark Worldwide, Inc. Personal care products and methods for inhibiting the adherence of flora to skin
US7854927B2 (en) 2004-05-11 2010-12-21 Ganeden Biotech, Inc. Methods and compositions for the dietary management of autoimmune disorders
WO2006076780A1 (en) * 2004-12-17 2006-07-27 Gielen Cornelis Use of non-pathogenic bacterial strains in cleaning and milking an animal
EP2270131A1 (de) 2005-05-31 2011-01-05 The Iams Company Probiotische Katzen-Laktobazillen
PL1885383T3 (pl) 2005-05-31 2017-06-30 Iams Europe B.V. Kocie probiotyczne bifidobakterie
EP2066785B1 (de) 2006-08-11 2023-02-01 Novozymes Biologicals, Inc. Bakterienkulturen und zusammensetzungen mit bakterienkulturen
US9283297B2 (en) * 2006-11-17 2016-03-15 Sca Hygiene Products Ab Sanitary article comprising a microbe-inhibiting composition
EP2125046A1 (de) * 2006-12-19 2009-12-02 Ferrosan A/S Wund- oder gewebeverband mit milchsäurebakterien
JP5799299B2 (ja) 2007-02-01 2015-10-21 ザ・アイムス・カンパニーＴｈｅ Ｉａｍｓ Ｃｏｍｐａｎｙ ブドウ糖代謝拮抗物質、アボカド又はアボカド抽出物を使用する、哺乳動物における炎症及びストレスの低下方法
US20080219939A1 (en) * 2007-03-07 2008-09-11 Grune Guerry L Sunblock formulations
TW200904340A (en) * 2007-05-11 2009-02-01 Mannatech Inc Processing of natural polysaccharides by selected non-pathogenic microorganisms and methods of making and using the same
GB0714338D0 (en) * 2007-07-23 2007-09-05 Sinclair Pharmaceuticals Ltd method
WO2009029267A1 (en) 2007-08-29 2009-03-05 Ganeden Biotech, Inc. Baked goods
FR2930443B1 (fr) 2008-04-29 2010-06-25 Oreal Produit extemporane de soin a base d'un lyophilisat de microorganisme et de tensioactif(s) de hlb superieur ou egal a 12
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US8617537B2 (en) 2008-06-10 2013-12-31 Biogaia Ab Controlled activation of the reuterin-production machinery of lactobacillus
FR2938437B1 (fr) * 2008-11-19 2020-03-27 Société des Produits Nestlé S.A. Utilisation cosmetique de microorganisme pour le traitement des peaux grasses
EP2348888B1 (de) 2008-10-16 2016-08-10 Ganeden Biotech, Inc. Probiotische zusammensetzung auf kornbasis
BE1018722A5 (nl) * 2009-04-17 2011-07-05 Cruysberghs Rudiger Een biologische samenstelling voor het behandelen van huisdieren en hun levensomgeving.
CA2760325A1 (en) 2009-04-29 2010-11-04 Ganeden Biotech, Inc. Dead bacillus coagulans bacteria and uses thereof for boosting the immune system
WO2011003062A2 (en) * 2009-07-03 2011-01-06 James Madison University Probiotic compositions and processes thereof
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
US8771669B1 (en) 2010-02-09 2014-07-08 David Gordon Bermudes Immunization and/or treatment of parasites and infectious agents by live bacteria
US8524220B1 (en) 2010-02-09 2013-09-03 David Gordon Bermudes Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria
US9301982B2 (en) 2010-04-14 2016-04-05 Ganeden Biotech, Inc. Probiotic confection and lipid compositions
CN102690764B (zh) * 2010-05-20 2013-07-10 上海交通大学 用于制备l-乳酸的凝结芽孢杆菌及其应用方法
IT1401447B1 (it) * 2010-06-09 2013-07-26 Copan Italia Spa Metodo per il trasferimento quantitativo di analiti
IT1403618B1 (it) 2011-01-05 2013-10-31 Copan Italia Spa Procedimento per realizzare un dispositivo per il prelievo ed il trasferimento di campioni per biologia molecolare
DE102011009798B4 (de) 2011-01-31 2015-03-05 Merz Pharma Gmbh & Co. Kgaa Balneologische lipidhaltige probiotische Zubereitungen für kosmetische / dermatologische / medizinische Anwendungen
EP3431581B1 (de) 2011-02-15 2022-04-06 Novozymes Biologicals, Inc. Geruchsminderung bei reinigungsmaschinen und reinigungsverfahren
WO2012135499A1 (en) 2011-03-31 2012-10-04 Ganeden Biotech, Inc. Probiotic sports nutrition compositions
EP2809301A1 (de) 2012-01-31 2014-12-10 Biosoma B.V. Verfahren zur verabreichung eines probiotikums
US20130251695A1 (en) * 2012-02-28 2013-09-26 Ganeden Biotech, Inc. Cosmetic Compositions
KR20150065170A (ko) 2012-08-07 2015-06-12 탑제닉스, 인크. 관심있는 화합물을 발현하는 형질전환된 박테리아를 포함하는 국소 조성물
US20150290107A1 (en) 2013-03-14 2015-10-15 3 In 1 Dental Pllc Compositions for treatment of xerostomia and for tooth treatment
RU2015156089A (ru) * 2013-05-31 2017-07-06 Новозимс Биоаг А/С Композиции и способы для усиления прорастания
US10152529B2 (en) 2013-08-23 2018-12-11 Elwha Llc Systems and methods for generating a treatment map
US9557331B2 (en) 2013-08-23 2017-01-31 Elwha Llc Systems, methods, and devices for assessing microbiota of skin
US9805171B2 (en) 2013-08-23 2017-10-31 Elwha Llc Modifying a cosmetic product based on a microbe profile
US20150057574A1 (en) 2013-08-23 2015-02-26 Elwha Llc Selecting and Delivering Treatment Agents based on a Microbe Profile
US9390312B2 (en) 2013-08-23 2016-07-12 Elwha Llc Systems, methods, and devices for assessing microbiota of skin
US9456777B2 (en) 2013-08-23 2016-10-04 Elwha Llc Systems, methods, and devices for assessing microbiota of skin
US10010704B2 (en) 2013-08-23 2018-07-03 Elwha Llc Systems, methods, and devices for delivering treatment to a skin surface
US9811641B2 (en) 2013-08-23 2017-11-07 Elwha Llc Modifying a cosmetic product based on a microbe profile
JP6230349B2 (ja) * 2013-09-13 2017-11-15 株式会社ネイチャーサポート 入浴治療用培養液及び培養液循環装置
US9974311B2 (en) 2013-09-23 2018-05-22 Stewart Group Trading Inc. Impregnated odour control products and methods of making the same
EP2856896A1 (de) * 2013-09-23 2015-04-08 Life Science TGO, SRL Imprägnierte Geruchskontrollprodukte und Verfahren zur Herstellung davon
US10653729B2 (en) * 2013-10-25 2020-05-19 Nch Corporation Delivery system and probiotic composition for animals and plants
US9596861B2 (en) 2013-12-24 2017-03-21 Sami Labs Limited Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof
US9737592B1 (en) 2014-02-14 2017-08-22 David Gordon Bermudes Topical and orally administered protease inhibitors and bacterial vectors for the treatment of disorders and methods of treatment
US10766799B2 (en) 2014-05-23 2020-09-08 Nch Corporation Method for improving quality of aquaculture pond water using a nutrient germinant composition and spore incubation method
CA2950950A1 (en) 2014-06-17 2015-12-23 TopGeniX, Inc. Topical formulations for uv protection
MY174855A (en) * 2014-08-29 2020-05-19 Sami Labs Ltd Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof
US10004768B2 (en) 2014-09-25 2018-06-26 Iryohojin Kiyokai Treatment of atopic dermatitis and infectious dermatitis with biological spa therapy
WO2016161074A1 (en) 2015-03-31 2016-10-06 Gojo Industries, Inc. Synergistic compositions and methods for mitigating skin irritation and enhancing skin barrier function
WO2017011785A1 (en) 2015-07-15 2017-01-19 National Concessions Group Inc. Topical antiviral formulations and methods of using the same
CH711598B1 (de) * 2015-10-16 2017-06-15 Swiss Cream Cosmetics Scc Gmbh Verfahren zur Herstellung von dermatologischen und kosmetischen Präparaten mit ausgeprägten lamellaren Strukturen unter Verwendung von Phosphatidylcholin und Fermentation durch Mikroorganismen.
US20180325117A1 (en) * 2015-10-30 2018-11-15 Zprobiotics Inc. Dba Zbioscience Inc. Probiotic compositions and uses thereof
BE1023416B1 (nl) 2016-02-26 2017-03-14 Chrisal Nv Synbiotisch preparaat
CA3018866C (en) 2016-03-31 2024-03-26 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
US20170281660A1 (en) * 2016-03-31 2017-10-05 Gojo Industries, Inc. Topical composition for reducing pathogen binding
JP2019510037A (ja) 2016-03-31 2019-04-11 ゴジョ・インダストリーズ・インコーポレイテッド 抗菌ペプチド刺激性洗浄組成物
US12097226B2 (en) 2016-04-05 2024-09-24 Nch Corporation System and method for using a single-serve nutrient spore composition for small scale farm applications
CN108884434B (zh) 2016-04-05 2023-06-09 Nch公司 富含营养的萌发剂组合物及孢子培养方法
US10897922B2 (en) 2016-04-05 2021-01-26 Nch Corporation Composition and method for germinative compounds in probiotic food and beverage products for human consumption
JP2020500860A (ja) 2016-11-23 2020-01-16 ゴジョ・インダストリーズ・インコーポレイテッド プロバイオティック／プレバイオティックな有効成分を含む消毒薬組成物
FR3059237B1 (fr) 2016-11-30 2021-04-30 Nolivade Utilisation d'une composition bacterienne pour traiter des pathologies animales
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US20180344627A1 (en) * 2017-06-06 2018-12-06 Muhammed Majeed Skin care applications of extracellular metabolites from bacillus coagulans
WO2019018424A1 (en) * 2017-07-18 2019-01-24 Aobiome Llc MICROORGANISMS OXIDIZING AMMONIA FOR USE AND ADMINISTRATION TO THE VISUAL AND AUDITIVE SYSTEMS
EP3675812A4 (de) * 2017-08-31 2021-06-02 Sami Labs Limited Anti-verschmutzungszusammensetzungen mit bacillus coagulans
EP3678636A4 (de) * 2017-09-07 2021-06-09 Technion Research & Development Foundation Limited Topische kits und zusammensetzungen und verwendung davon
WO2019180748A1 (en) * 2018-03-21 2019-09-26 Panjab University Probiotic formulation and uses thereof
US11401500B2 (en) 2018-08-29 2022-08-02 Nch Corporation System, method, and composition for incubating spores for use in aquaculture, agriculture, wastewater, and environmental remediation applications
AR117008A1 (es) * 2018-11-06 2021-07-07 Monsanto Technology Llc Procesos para el tratamiento de suspensiones de microbios
CN113163757B (zh) * 2018-11-29 2024-02-13 罗地亚经营管理公司 瓜尔胶衍生物在生物杀真菌剂组合物中的用途
EP3685669A1 (de) * 2019-01-23 2020-07-29 Chrisal NV Zusammensetzung zur dekontamination und inokulation von oberflächen
EP3952848A1 (de) 2019-04-09 2022-02-16 Dermbiont, Inc. Zusammensetzungen und verfahren zur verbesserung der gesundheit und zur behandlung und vorbeugung von mit pathogenen keimen assoziierten krankheiten, störungen und zuständen
US11576937B2 (en) 2020-02-06 2023-02-14 Nch Corporation Method of reducing gut inflammation reduction in humans by consuming a heated probiotic composition
BE1028228B1 (nl) * 2020-04-22 2021-11-30 Living Tech Cvba Werkwijze voor het verlagen van de werkzame verblijftijd van viruspartikels op oppervlakken en samenstelling hiervoor
CN113142196A (zh) * 2020-09-04 2021-07-23 江苏省农业科学院 一种解淀粉芽孢杆菌干悬浮剂及其制备方法
CN115011739B (zh) * 2022-08-03 2022-11-01 南京邦康生物技术有限公司 一种益生菌的生产控制方法与系统
CN115191448B (zh) * 2022-08-12 2023-06-23 宝鸡市烟草公司麟游分公司 防治烟草花叶病毒的微生物植物提取物复合剂及其应用
WO2024062470A1 (en) 2022-09-21 2024-03-28 Moraz Medical Herbs (1989) Ltd. Dermal and cosmetic compositions
CN116064330B (zh) * 2023-01-10 2024-05-03 北京工商大学 凝结芽孢杆菌及其应用

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1285173A (en) * 1968-09-09 1972-08-09 Glaxo Lab Ltd AN alpha-AMYLASE AND A PROCESS FOR ITS PREPARATION
GB1204017A (en) * 1968-10-11 1970-09-03 Sankyo Co Animal feed compositions
US4323651A (en) * 1974-12-04 1982-04-06 R. J. Reynolds Tobacco Company Thermostable lactase derived from bacillus
JPS52102419A (en) * 1976-02-23 1977-08-27 Seikenkai Lactic acid producing bacillus preparation
US4110477A (en) * 1977-05-13 1978-08-29 Kabushiki Kaisha Naruse Fermentation Laboratory Method for producing natto containing lactic acid bacteria
JPS55113718A (en) * 1979-02-27 1980-09-02 Yakult Honsha Co Ltd Antitumor agent
JPS60149527A (ja) * 1984-01-17 1985-08-07 Seikenkai 生体内脱臭剤
US5000939A (en) * 1984-06-12 1991-03-19 Colgate-Palmolive Company Dentifrice containing stabilized enzyme
JPS6396107A (ja) * 1986-10-11 1988-04-27 Shiseido Co Ltd 粉末化粧料
GB8701234D0 (en) * 1987-01-21 1987-02-25 Agricultural Genetics Co Strain of microorganism
US5413960A (en) * 1987-05-01 1995-05-09 Biogaia Ab Antibiotic reuterin
JPH01199575A (ja) * 1988-02-04 1989-08-10 Rikagaku Kenkyusho 新規なサイクロマルトデキストリン・グルカノトランスフェラーゼ及びその製造法
IT1227154B (it) * 1988-08-05 1991-03-19 A Tosi Farmaceutici S R L Nova Composizioni farmaceutiche per uso ginecologico a base di lattobacilli
AT391323B (de) * 1989-03-10 1990-09-25 Jungbunzlauer Ag Mikroorganismus der species bacillus coagulans sowie ein verfahren zur herstellung von optisch reiner l(+)-milchsaeure
JPH02255620A (ja) * 1989-03-28 1990-10-16 Kazuo Tsubaki 抗白癬菌剤およびその製造方法、利用方法
JPH0367552A (ja) * 1989-05-24 1991-03-22 Toyo Jozo Co Ltd 安定な芽胞形成生菌製剤およびその製造法並びにペレット
US5283059A (en) * 1989-05-24 1994-02-01 Asahi Kasei Kogyo Kabushiki Kaisha Process for producing a stabilized store-forming viable microorganisms preparation containing Bacillus cereus
US5371011A (en) * 1989-07-10 1994-12-06 Zeneca Corp. Mold control in forage
JP2866114B2 (ja) * 1989-09-20 1999-03-08 株式会社資生堂 化粧料
KR920005685B1 (ko) * 1989-11-09 1992-07-13 일동제약 주식회사 유산균을 이용한 항 종양제
US5045314A (en) * 1989-11-14 1991-09-03 The United States Of America As Represented By The Secretary Of Agriculture Control of parasitic nematode ova/larvae with a bacillus laterosporus
DE4001611C1 (de) * 1990-01-20 1991-02-28 Skw Trostberg Ag, 8223 Trostberg, De
US5200336A (en) * 1990-07-02 1993-04-06 New England Biolabs, Inc. Restriction endonuclease obtainable foam bacillus coagulans and a process for producing the same
JPH0761255B2 (ja) * 1990-10-31 1995-07-05 旭化成工業株式会社 安定化芽胞形成生菌製剤の製造法
CA2096242A1 (en) * 1990-11-14 1992-05-15 Peter Ghosh Anti-inflammatory composition derived from emu oil
CA2037311C (en) * 1990-12-04 1999-04-13 Boyd J. O'donnell Method of inhibiting fungi
IT1262927B (it) * 1992-01-14 1996-07-22 Consiglio Nazionale Ricerche Batteri sporgenti e loro impiego come probiotici
FI92498C (fi) * 1992-06-10 1994-11-25 Valio Meijerien Uusi mikro-organismikanta, sitä sisältävät bakteerivalmisteet ja näiden käyttö hiivojen ja homeiden torjuntaan
WO1994011492A1 (en) * 1992-11-12 1994-05-26 Chr. Hansen's Laboratory, Inc. Method of favorably modifying poultry intestinal microflora
ES2250969T3 (es) * 1994-03-29 2006-04-16 Novozymes A/S Amilasa alcalina de bacilo.
JPH08175921A (ja) * 1994-12-22 1996-07-09 Idemitsu Kosan Co Ltd 農園芸用殺菌剤組成物
US5728390A (en) * 1995-09-01 1998-03-17 Isp Investments Inc. Cosmetic composition of an alpha or beta-hydroxy acid and a polyvinylpyrrolidone complexing agent
JPH09154535A (ja) * 1995-12-07 1997-06-17 Sanwa Kagaku Kenkyusho Co Ltd 納豆菌含有組成物
US7507402B1 (en) * 1997-04-18 2009-03-24 Ganeden Biotech, Inc. Topical use of probiotic Bacillus spores to prevent or control microbial infections
US6716435B1 (en) * 1997-04-18 2004-04-06 Ganeden Biotech, Inc. Absorbent product containing absorbent structure and Bacillus coagulans
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
US6461607B1 (en) * 1998-08-24 2002-10-08 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
WO2001013956A2 (en) * 1999-08-26 2001-03-01 Ganeden Biotech, Inc. Use of emu oil a carrier for antifungal, antibacterial, and antiviral medications

Also Published As

Publication number Publication date
EP1629846B1 (de) 2010-12-29
ATE493139T1 (de) 2011-01-15
US20090186057A1 (en) 2009-07-23
DE69832267T2 (de) 2006-08-10
EP1629846A2 (de) 2006-03-01
US20110274676A1 (en) 2011-11-10
JP2009269922A (ja) 2009-11-19
ATE308987T1 (de) 2005-11-15
DE69842080D1 (de) 2011-02-10
EP1629846A3 (de) 2008-02-27
EP0975227B1 (de) 2005-11-09
EP0975227A4 (de) 2003-05-21
AU749001B2 (en) 2002-06-13
JP4678896B2 (ja) 2011-04-27
EP0975227A1 (de) 2000-02-02
CA2287451A1 (en) 1998-10-29
AU7110298A (en) 1998-11-13
CA2287451C (en) 2014-06-10
JP2002512615A (ja) 2002-04-23
WO1998047374A1 (en) 1998-10-29
ES2255730T3 (es) 2006-07-01

Similar Documents

Publication Publication Date Title
DE69832267D1 (de) Oberflächige verwendung von probiotischen bacillussporen zur verhinderung oder bekämpfung von mikrobiellen infektionen
CA2382840A1 (en) Improved topical compositions containing probiotic bacteria, spores, and extracellular products and uses thereof
DE69420142D1 (de) Thermoplastische Elastomere Copolymere und diese enthaltendes Haar und Hautflegemittel
DE69421188D1 (de) Thermoplastische und elastomere silikonpfropfcopolymere und diese enthaltende haar- und hautpflegemittel
ATE193025T1 (de) Thermoplastische elastomere copolymere und diese enthaltendes haar- und hautpflegemittel
ES2119897T3 (es) Procedimiento y composicion para el cuidado de la piel.
DE60012026D1 (de) Verwendung von emu-öl als träger für fungizide, antibakterielle und antivirale arzneien
GR3033501T3 (en) Silicone grafted thermoplastic elastomeric copolymers and hair and skin care compositions containing the same
EP1050297A3 (de) Eine Lotion enthaltende Gewebe enthaltend eine pH-Buffer Verbindung für die Haut
DE59911740D1 (de) Topisch anwendbare mittel gegen nagelpilzerkrankungen
ES2127490T3 (es) Utilizacion de un aceite rico en acido petroselenico como agente hidratante.
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
FR2761885B1 (fr) Utilisation d'au moins un extrait d'irvingia gabonensis dans un produit cosmetique et/ou pharmaceutique
TR199900661T2 (xx) Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m�
ATE307561T1 (de) Verwendung von spezifischen fettstoffen zur modifizierung der physico-chemischen eigenschaften der haut und/oder der schleimhaut als mittel zur verhinderung oder reduzierung der adhäsion von mikro-organismen darauf
EP0402933A3 (de) Anwendung von feuchtem Sucralfatgel als Träger für Arzneimittel mit topischen Aktivitäten und für kosmetische Präparate
KR900005316B1 (ko) 미생물을 함유한 헤어토닉 조성물
WO2003000222A3 (en) Cosmetic preparation with anti-wrinkle action
JP5715666B2 (ja) 化粧料用組成物
CA2214933A1 (en) Herbal salve
MX9705234A (es) Composiciones cosmeticas anhidras con agentes dermatologicamente activos.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition